Autonomix Net Income From Continuing Ops from 2010 to 2026
| AMIX Stock | 0.39 0.01 1.50% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -10.3 M | Current Value -10.8 M | Quarterly Volatility 4.5 M |
Check Autonomix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autonomix Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 156.5 K, Interest Expense of 94.6 K or Selling General Administrative of 5.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.42. Autonomix financial statements analysis is a perfect complement when working with Autonomix Medical Valuation or Volatility modules.
Autonomix | Net Income From Continuing Ops | Build AI portfolio with Autonomix Stock |
The evolution of Net Income From Continuing Ops for Autonomix Medical Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Autonomix Medical compares to historical norms and industry peers.
Latest Autonomix Medical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Autonomix Medical Common over the last few years. It is Autonomix Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Autonomix Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Autonomix Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (4,338,674) | |
| Coefficient Of Variation | (103.29) | |
| Mean Deviation | 3,592,089 | |
| Median | (1,990,000) | |
| Standard Deviation | 4,481,455 | |
| Sample Variance | 20.1T | |
| Range | 13.4M | |
| R-Value | (0.70) | |
| Mean Square Error | 11T | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | (617,629) | |
| Total Sum of Squares | 321.3T |
Autonomix Net Income From Continuing Ops History
About Autonomix Medical Financial Statements
Autonomix Medical investors use historical fundamental indicators, such as Autonomix Medical's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Autonomix Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.3 M | -10.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.